# Trade Mark Journal No.2026/010 6 March 2026

## WO0000001902777 (9,10)

Office of origin: United States of America

Date of International Registration:14 January 2026
Date of designation in the UK: 14 January 2026

International priority date claimed: 17 July 2025 (United States of America) (99289673)

Class 9
  Downloadable computer software for monitoring blood glucose and managing diabetes; downloadable computer software for mobile phones, namely, software for monitoring blood glucose and managing diabetes.
Class 10
  Medical products, namely, biofeedback sensors; medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; glucose meters; wearable monitors used to measure biometric data for medical use.

Biolinq Incorporated

Representative: John Paul Oleksiuk Cooley LLP, 1299 Pennsylvania Ave., NW, Washington DC 20004, UNITED STATES OF AMERICA